Fund Holdings — Catalio Capital Management, LP

Total Portfolio Value:
$478.70M
Total Bought:
$136.54M
Total Sold:
$240.56M
Net Transaction:
-$104.03M
Notable People:
Catalio Capital Gp, Llc
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Dianthus Therapeutics, Inc.(DNTH)653,572560,308-93,264$26.93M$47.02M9.82%+$20.09M
BridgeBio Pharma, Inc.(BBIO)410,700432,014+21,314$31.41M$32.08M6.70%+$666.9K
Ascendis Pharma A/SADR(ASND)119,265129,111+9,846$25.43M$29.53M6.17%+$4.10M
Bristol-Myers Squibb Company(BMY)647,899420,727-227,172$34.95M$25.52M5.33%-$9.43M
Syndax Pharmaceuticals, Inc.(SNDX)1,196,8071,043,670-153,137$25.14M$24.38M5.09%-$764.8K
Gilead Sciences, Inc.(GILD)289,312163,905-125,407$35.51M$22.84M4.77%-$12.67M
Terns Pharmaceuticals Inc136,958409,031+272,073$5.53M$21.56M4.50%+$16.03M
Definium Therapeutics, Inc.(DFTX)01,037,984+1,037,984$0$19.62M4.10%+$19.62M
Soleno Therapeutics Inc360,340577,808+217,468$16.68M$19.35M4.04%+$2.66M
Boston Scientific Corporation(BSX)360,428299,318-61,110$34.37M$18.78M3.92%-$15.58M
Ultragenyx Pharmaceutical Inc.(RARE)162,550850,797+688,247$3.74M$17.82M3.72%+$14.09M
Incyte Corporation(INCY)0182,101+182,101$0$17.14M3.58%+$17.14M
Cytokinetics, Incorporated(CYTK)258,381215,501-42,880$16.42M$14.20M2.97%-$2.21M
Natera, Inc.(NTRA)62,27370,907+8,634$14.27M$14.18M2.96%-$85.4K
Corvus Pharmaceuticals, Inc.(CRVS)0891,933+891,933$0$13.05M2.73%+$13.05M
Structure Therapeutics IncADS252,901255,379+2,478$17.59M$12.31M2.57%-$5.28M
Mineralys Therapeutics, Inc.(MLYS)331,849439,041+107,192$12.04M$11.89M2.48%-$149.2K
Edwards Lifesciences Corp187,048144,607-42,441$15.95M$11.58M2.42%-$4.37M
Veradermics, Incorporated(MANE)0173,582+173,582$0$10.96M2.29%+$10.96M
Adaptive Biotechnologies Corporation(ADPT)821,195722,784-98,411$13.34M$10.03M2.10%-$3.30M
Heartflow, Inc.(HTFL)113,857403,588+289,731$3.32M$9.82M2.05%+$6.50M
Kalvista Pharmaceuticals Inc0426,551+426,551$0$8.59M1.79%+$8.59M
uniQure N.V.SHS(QURE)288,345491,116+202,771$6.90M$8.03M1.68%+$1.13M
Disc Medicine, Inc.(IRON)110,427122,978+12,551$8.77M$7.86M1.64%-$905.8K
Septerna, Inc.(SEPN)294,360294,3600$8.21M$7.07M1.48%-$1.13M
ABIVAX Société AnonymeADS(ABVX)98,51447,193-51,321$13.29M$5.25M1.10%-$8.03M
Dyne Therapeutics, Inc.(DYN)519,715282,954-236,761$10.17M$5.13M1.07%-$5.04M
Eledon Pharmaceuticals, Inc.(ELDN)1,259,8201,639,816+379,996$1.90M$5.05M1.06%+$3.15M
Karyopharm Therapeutics Inc.(KPTI)142,984897,709+754,725$1.05M$5.00M1.04%+$3.95M
Supernus Pharmaceuticals, Inc.(SUPN)257,46562,019-195,446$12.80M$3.21M0.67%-$9.59M
Protara Therapeutics, Inc.(TARA)1,446,254580,024-866,230$7.71M$3.02M0.63%-$4.69M
Phathom Pharmaceuticals, Inc.(PHAT)698,996247,767-451,229$11.60M$2.75M0.58%-$8.84M
Newamsterdam Pharma Company
ORDINARY SHARES
083,554+83,554$0$2.67M0.56%+$2.67M
Tyra Biosciences, Inc.(TYRA)067,285+67,285$0$2.58M0.54%+$2.58M
Immunocore Holdings plcADS(IMCR)084,352+84,352$0$2.54M0.53%+$2.54M
Fractyl Health, Inc.(GUTS)5,491,8665,491,8660$12.08M$2.51M0.53%-$9.57M
Hyperfine, Inc.CL A(HYPR)1,320,0411,320,0410$1.29M$1.43M0.30%+$132.9K
Metagenomi Therapeutics, Inc.(MGX)528,993528,9930$857.0K$708.9K0.15%-$148.1K
Ataibeckley Inc0196,858+196,858$0$696.9K0.15%+$696.9K
Faeth Therapeutics, Inc.(FTH)14,71814,7180$157.0K$463.9K0.10%+$306.9K
Outset Medical, Inc.(OM)118,279118,2790$438.8K$454.2K0.09%+$15.4K
Adma Biologics Inc564,4610-564,461$10.30M$0—-$10.30M
Arcellx Inc
COMMON STOCK
156,1090-156,109$10.18M$0—-$10.18M
Atai Beckley NvSHS196,8580-196,858$805.1K$0—-$805.1K
Billiontoone IncCL A25,5050-25,505$2.09M$0—-$2.09M
Eli Lilly and Company(LLY)25,9230-25,923$27.86M$0—-$27.86M
Fulcrum Therapeutics, Inc.(FULC)201,3010-201,301$2.28M$0—-$2.28M
GRAIL, Inc.(GRAL)30,3130-30,313$2.59M$0—-$2.59M
Intuitive Surgical, Inc.(ISRG)27,2090-27,209$15.41M$0—-$15.41M
Johnson & Johnson(JNJ)120,8400-120,840$25.01M$0—-$25.01M
Ocular Therapeutix, Inc.(OCUL)714,5010-714,501$8.67M$0—-$8.67M
Olema Pharmaceuticals, Inc.(OLMA)267,0580-267,058$6.68M$0—-$6.68M
Palvella Therapeutics, Inc.(PVLA)10,4520-10,452$1.09M$0—-$1.09M
Regeneron Pharmaceuticals, Inc.(REGN)29,7970-29,797$23.00M$0—-$23.00M
Page 1 of 1
Catalio Capital Management, LP — 13F Holdings — Q1 2026 | TickerTrail